![Nicholas Haft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Haft
Founder at
Delix Therapeutics, Inc.
Profile
Nicholas Haft is the founder of Delix Therapeutics, Inc. Mr. Haft is currently the Director at Arcos Ventures SPV LLC since 2015.
Formerly, Mr. Haft was an Independent Director at Finch Therapeutics Group, Inc. from 2020 to 2023.
Mr. Haft completed undergraduate education at The Wharton School of the University of Pennsylvania.
Nicholas Haft active positions
| Companies | Position | Start |
|---|---|---|
Delix Therapeutics, Inc.
 Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to reduce and alleviate mental suffering | Founder | - |
Arcos Ventures SPV LLC | Chief Executive Officer | 2015-03-31 |
Former positions of Nicholas Haft
| Companies | Position | End |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Director/Board Member | 2023-06-22 |
Training of Nicholas Haft
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
27
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Finch Therapeutics Group, Inc.
 Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Arcos Ventures SPV LLC | |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to reduce and alleviate mental suffering | Health Technology |
- Stock Market
- Insiders
- Nicholas Haft
